Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing

Journal of Clinical Investigation

Volumn 100, Issue 1, 1997, Pages 204-215

  Hershberg, Robert M ^a,b   Framson, Paul E ^a   Cho, Diane H ^a   Lee, Lawrence Y ^a   Kovats, Susan ^b   Beitz, Jill ^c   Blum, Janice S ^c   Nepom, Gerald T ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

Antigen presentation; Human; Inflammatory bowel disease; Intestinal mucosa; T lymphocytes

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; HLA ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; ENTERITIS; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INTESTINE CELL; INTESTINE EPITHELIUM; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0030749842     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119514     Document Type: Article

References (56)

1. Mayer, L., D. Eisenhardt, P. Salomon, W. Bauer, R. Plous, and L. Piccinini. 1991. Expression of class II molecules on intestinal epithelial cells in humans. Differences between normal and inflammatory bowel disease. Gastroenterology. 100:3-12.
2. Bland, P.W., and C.V. Whiting. 1992. Induction of MHC class II gene products in rat intestinal epithelium during graft-versus-host disease and effects on the immune function of the epithelium. Immunology. 75:366-371.
3. Ciclitira, P.J., J.M. Nelufer, H.J. Ellis, and D.J. Evans. 1986. The effect of gluten on HLA-DR in the small intestinal epithelium of patients with Coeliac disease. Clin. Exp. Immunol. 63:101-104.
4. Germain, R.N. 1994. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell. 76:287-299.
5. Powrie, F. 1995. T cells in inflammatory bowel disease: protective and pathogenic roles. Immunity. 3:171-174.
6. Chen, Y., J. Inobe, and H.L. Weiner. 1995. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: both CD4+ and CD8+ cells mediate active suppression. J. Immunol. 155:910-916.
7. Garside, P., M. Steel, F.Y. Liew, and A.M. Mowat. 1995. CD4+ but not CD8+ T cells are required for the induction of oral tolerance. Int. Immunol. 7: 501-504.
8. Barone, K.S., S.L. Jain, and J.G. Michael. 1995. Effect of in vivo depletion of CD4+ and CD8+ cells on the induction and maintenance of oral tolerance. Cell. Immunol. 163:19-29.
9. Wolf, P.R., and H.L. Ploegh. 1995. How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. Annu. Rev. Cell Dev. Biol. 267-306.
10. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293.
11. Chang, C.H., and R.A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765-767.
12. Vidal, K., C. Samarut, J.-P. Magaud, J.-P. Revillard, and D. Kaiserlian. 1993. Unexpected lack of reactivity of allogeneic anti-Ia monoclonal antibodies with MHC class II molecules expressed by mouse intestinal epithelial cells. J. Immunol. 151:4642-4650.
13. Bland, P.W., and D.M. Kambarage. 1991. Antigen handling by the epithelian and lamina propria macrophages. Gastroenterol. Clin. North Am. 20: 577-596.
14. Mayer, L., and R. Shlien. 1987. Evidence for function of Ia molecules on gut epithelial cells in man. J. Exp. Med. 166:1471-1483.
15. Bland, P.W., and L.G. Warren. 1986. Antigen presentation by epithelial cells of the rat small intestine. I. Kinetics, antigen specificity and blocking by anti-Ia antisera. Immunology. 58:1-7.
16. Kaiserlian, D., K. Vidal, and J.-P. Revillard. 1989. Murine enterocytes can present soluble antigen to specific class II-restricted CD4+ T cells. Eur. J. Immunol. 19:1513-1516.
17. Kovats, S., S. Drover, W. Marshall, D. Freed, P. Whiteley, G.T. Nepom, and J.S. Blum. 1994. Coordinate defects in HLA class II expression and antigen presentation in bare lymphocyte syndrome. J. Exp. Med. 179:2017-2022.
18. Leech, N., W. Hagopian, J.A. Hansen, G.T. Nepom, and A. Kitabchi. 1997. GAD65 and islet cell autoantibodies are associated with HLA class II alleles in Black Americans. Autoimmunity. In press.
19. MacDonald, M.J., J. Gottschall, J.B. Hunter, and K.L. Winter. 1986. HLA-DR4 in insulin-dependent diabetic parents and their diabetic offspring: a clue to dominant inheritance. Proc. Natl. Acad. Sci. USA. 83:7049-7053.
20. Inoko, H., A. Ando, K. Tsuji, K. Matsuki, T. Juji, and Y. Honda. 1986. HLA-DQ beta chain DNA restriction fragments can differentiate between healthy and narcoleptic individuals with HLA-DR2. Immunogenetics. 23:126-128.
21. Cohen-Haguenauer, O., E. Robbins, C. Massart, M. Busson, I. Deschamps, J. Hors, J.M. Lalouel, J. Dausset, and D. Cohen. 1985. A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA. 82:3335-3339.
22. Kovats, S., G.T. Nepom, M. Coleman, B. Nepom, W.W. Kwok, and J.S. Blum. 1995. Deficient antigen presenting cell function in multiple genetic complementation groups of type II bare lymphocyte syndrome. J. Clin. Invest. 96: 217-223.
23. Kwok, W.W., D. Schwarz, B.S. Nepom, P.S. Thurtle, R.A. Hock, and G.T. Nepom. 1988. HLA-DQ molecules form α-β heterodimers of mixed allotype. J. Immunol. 141:3123-3127.
24. Denzin, L.K., N.F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity. 1:595-606.
25. Woods, A., H.Y. Chen, M.E. Trumbauer, A. Sirotina, R. Cummings, and D.M. Zaller. 1994. Human major histocompatibility complex class II-restricted T cell responses in transgenic mice. J. Exp. Med. 180:173-181.
26. Tuosto, L., R.W. Karr, X.T. Fu, R.R. Olson, E. Cundari, E. Piccolella, R. Lechler, and G. Lombardi. 1994. Different regions of the N-terminal domains of HLA-DR1 influence recognition of individual peptide-DR1 complexes. Hum. Immunol. 40:312-322.
27. Weiner, G.J., and M.S. Kaminski. 1990. Anti-idiotypic antibodies recognizing stable epitopes limit the emergency of idiotype variants in a murine B cell lymphoma. J. Immunol. 144:2436-2445.
28. Barrett, A.J. 1980. Fluorimetric assays for Cathepsin B and Cathepsin H with methylcoumarylamide substrates. Biochem. J. 187:909-912.
29. Barrett, A.J., and H. Kirschke. 1981. Cathepsin B, Cathepsin H, and Cathepsin L. Methods Enzymol. 80:535-561.
30. Diment, S., M.S. Leech, and P.D. Stahl. 1988. Cathepsin D is membrane-associated in macrophage endosomes. J. Biol. Chem. 263:6901-6907.
31. Momburg, F., K. Koretz, and A. Von Herbay. 1988. Nonimmune human cells can express MHC class II antigens in the absence of invariant chain - an immunohistological study on normal and chronically inflamed small intestine. Clin. Exp. Immunol. 72:367-372.
32. Sanderson, I.R., A.J. Ouellette, E.A. Carter, and P.R. Harmatz. 1992. Ontogeny of class II MHC mRNA in the mouse small intestinal epithelium. Mol. Immunol. 29:1257-1263.
33. Furuhashi, M., A. Nakahara, H. Fukutomi, E. Kominami, D. Grube, and Y. Uchiyama. 1991. Immunocytochemical localization of cathepsins B, H, and L in the rat gastro-duodenal mucosa. Histochemistry. 95:231-239.
34. Mellins, E., L. Smith, B. Arp, T. Cotner, E. Celis, and D. Pious. 1990. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature (Lond.). 343:71-74.
35. Roche, P.A. 1995. HLA-DM: an in vivo facilitator of MHC class II peptide loading. Immunity. 3:259-262.
36. Madara, J.L., and J. Stafford. 1989. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83: 724-727.
37. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:707-716.
38. Pinet, V., M. Vergelli, R. Martin, O. Bakke, and E.O. Long. 1995. Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature (Lond.). 375:603-604.
39. Zhong, G., P. Romagnoli, and R.N. Germain. 1997. Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein. J. Exp. Med. 185:429-438.
40. Lencer, W.I., G. Strohmeier, S. Moe, S.L. Carlson, C.T. Constable, and J.L. Madara. 1995. Signal transduction by cholera toxin: processing in vesicular compartments does not require acidification. Am. J. Physiol. 269:G548-G557.
41. +-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266:17707-17712.
42. Pinet, V., M.S. Malnati, and E.O. Long. 1994. Two processing pathways for the MHC class II-restricted presentation of exogenous influenza virus antigen. J. Immunol. 152:4852-4860.
43. Ceman, S., and A.J. Sant. 1995. The function of invariant chain in class II-restricted antigen presentation. Semin. Immunol. 7:373-387.
44. Katz, J.F., C. Stebbins, E. Appella, and A.J. Sant. 1996. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. Med. 184:1747-1753.
45. Buus, S., and O. Werdelin. 1986. A group-specific inhibitor of lysosomal cysteine proteinases selectively inhibits both proteolytic degradation and presentation of the antigen dinitrophenyl-poly-L-lysine by guinea pig accessory cells to T cells. J. Immunol. 136:452-458.
46. Mizuochi, T., S.-T. Yee, M. Kasai, T. Kakiuchi, D. Muno, and E. Kominami. 1994. Both cathepsin B and cathepsin D are necessary for processing of ovalbumin as well as for degradation of class II MHC invariant chain. Immunol. Let. 43:189-193.
47. Rodriguez, G.M., and S. Diment. 1992. Role of cathepsin D in antigen presentation of ovalbumin. J. Immunol. 149:2894-2898.
48. Vidard, L., K.L. Rock, and B. Benacerraf. 1991. The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors. J. Immunol. 147:1786-1791.
49. Blumberg, R.S., C. Terhorst, P. Bleicher, F.V. McDermott, C.H. Allan, S.B. Landau, J.S. Trier, and S.P. Balk. 1991. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells. J. Immunol. 147:2518-2524.
50. Panja, A., A. Barone, and L. Mayer. 1994. Stimulation of lamina propria lymphocytes by intestinal epithelial cells: evidence for recognition of nonclassical restriction elements. J. Exp. Med. 179:943-950.
51. Blumberg, R.S., and S.P. Balk. 1994. Intraepithelial lymphocytes and their recognition of non-classical MHC molecules. Intern. Rev. Immunol. 11:15-30.
52. Bland, P.W., and C.V. Whiting. 1989. Antigen processing by isolated rat intestinal villus enterocytes. Immunology. 68:497-502.
53. Hoyne, G.F., M.G. Callow, M.-C. Kuo, and W.R. Thomas. 1993. Presentation of peptides and proteins by intestinal epithelial cells. Immunology. 80: 204-208.
54. Sidhu, N.K., G.M. Wright, R.J.F. Markham, W.P. Ireland, and A. Singh. 1992. Quantitative regional variation in the expression of major histocompatibility class II antigens in enterocytes of the mouse small intestine. Tissue Cell. 24:221-228.
55. Hashimoto, Y., and T. Komuro. 1988. Close relationships between the cells of the immune system and the epithelial cells in the rat small intestine. Cell Tissue Res. 254:41-47.
56. Zhang, Z., and J.G. Michael. 1990. Orally inducible immune unresponsiveness is abrogated by IFN-gamma treatment. J. Immunol. 144:4163-4165.